Healthcare

The healthcare landscape is evolving at a rapid pace, driven by groundbreaking advancements in AI, robotics, big data, and personalised medicine.

With growing industry challenges such as litigation risks and regulatory compliance, companies must now navigate balancing their IP strategy with regulatory and legal requirements.

At HGF, we are at the forefront of IP protection, empowering innovators to secure their breakthroughs and shape the future of healthcare with confidence. With our unmatched multidisciplinary approach, paired with extensive, award-winning experience in defending and challenging patents, your innovations can receive secure protection.

Find a specialist
Go to: Chemistry
Go to: MedTech

Latest updates

Case Law for Non-Reproducible Products as Prior Art

Does a non-reproducible commercially available product form part of the state of the art for a European patent application? This question was answered as “yes” in G 1/23 by the …

Read article

Fuelling IP: The “Charge” of the Century: How Battery Innovation Became the New Tech Race

As the world is reminded of the 1960s “space race” with the launch of Artemis II for humanity’s historic transit around the moon, it feels fitting that the European Patent …

Read article

PRESS RELEASE - Garreth Duncan joins HGF as a Partner in the London office

HGF is pleased to announce the appointment of Garreth Duncan who will be joining the firm as a Partner on 1st April 2026. Garreth joins our Chemistry and Pharmaceutical Group …

Read article

Fuelling IP: UK Sustainable Aviation Fuel – Direction of Travel

Last month, the UK government released their third provisional report on sustainable aviation fuel (SAF) use covering all of 2025. It is clear that momentum for SAF is building – …

Read article

IP Ingredients: The IP in Personalized nutrItion

Personalised nutrition is the provision of dietary advice which is tailored to a person based on their individual characteristics and lifestyle.  As analytical techniques become faster and cheaper, and AI …

Read article

The Patentability of Deuterated Pharmaceuticals: Insights from the EPO

Deuteration has emerged as a valuable strategy for tailoring the properties of pharmaceutical compounds.  With its expanding role in drug development, it is important to consider how the European Patent …

Read article

Mycelium Meets Market Reality: The Quiet Role of IP in Scaling Sustainable Materials

Fungal materials are increasingly used in applications ranging from sustainable packaging and leather alternatives to construction composites, textiles, and biotechnology. These developments are transforming fungi from a niche research subject …

Read article

T 0792/24: Novelty and Inventiveness of Second Medical Use Claims

The EPO Board of Appeal’s decision in T 0792/24 provides helpful guidance on the assessment of novelty and inventive step for European second medical use claims. In light of a …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our agrochemicals specialists.

Contact us